Martin VanTrieste is the President and CEO of Civica Rx, a groundbreaking, non-profit pharmaceutical company that's innovatively working to address our nation's generic drug shortages. For years, our domestic drug manufacturing and supply chains have eroded, resulting in shortages of anesthetics, antibiotics, cancer drugs, even sterile IV fluids necessary for delivering nearly every drug used in a surgical setting.
Martin, who was recently named one of Modern Healthcare's 100 Most Influential People in Healthcare, is working at the cutting edge with his team at Civica to make drug shortages a thing of the past.
Visit A Second Opinion's website here: https://asecondopinionpodcast.com/
Engage with us on social media at: Facebook Twitter Instagram
A Second Opinion with Senator Bill Frist, M.D.